[Development, rollout, and challenges of COVID-19 vaccines in Japan and globally]

Uirusu. 2021;71(1):41-44. doi: 10.2222/jsv.71.41.

[Article in Japanese]

Authors

Takeshi Arashiro, Tadaki Suzuki

PMID: 35526993
DOI: 10.2222/jsv.71.41

No abstract available

MeSH terms

COVID-19 Vaccines
COVID-19* / epidemiology
COVID-19* / prevention & control
Humans
Japan
SARS-CoV-2
Vaccination
Vaccines*

Substances

COVID-19 Vaccines
Vaccines